Compared with normal brain tissue, MEG3 was found to be downregulated in glioma and glioblastoma cell lines and overexpression of MEG3 leads to increased cell death and inhibition of cell proliferation [159]. This evidence concerns the gene MEG3 and central nervous system cancer.